Both in Pharmaceuticals
Stoke Therapeutics vs Generate Biomedicines
Over the past year STOK returned −9.4% and GENB returned −8.0%; their daily moves had a correlation of 0.51.
STOK −9.4% GENB −8.0%Growth of $1, one year, split-adjusted
| Metric | STOK | GENB |
|---|---|---|
| Price | $26.29 | $14.46 |
| Market cap | $1.70B | $1.86B |
| Today | −0.23% | −8.31% |
| 1 month | +1.1% | +4.8% |
| 6 months | −20.5% | — |
| Year to date | −17.2% | — |
| 1 year | −16.3% | — |
| Revenue growth (YoY) | −32.5% | — |
| Gross margin | 100.0% | 100.0% |
| Net margin | −660.8% | −1065.2% |
| P/E (TTM) | — | — |
| Price / sales | 61.5× | — |
| Net cash | $292.8M | $452.3M |
| Dividend yield | — | — |
| Volatility (60d) | 48.1% | — |
| Short % of float | 18.9% | 15.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).